Hypoxia Stimulates the EMT of Gastric Cancer Cells through Autocrine TGFβ Signaling

Junko Matsuoka, Masakazu Yashiro, Yosuke Doi, +14

PLoS ONE

Gastric Cancer CellsPathologyCancer BiologyTumor BiologyEpithelial-mesenchymal Transition +15

Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells

Osamu Shinto, Masakazu Yashiro, Hidemi Kawajiri, +4

British Journal of Cancer

Cancer stem cell‐like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma

Takafumi Nishii, Masakazu Yashiro, Osamu Shinto, +3

Cancer Science

Flow Cytometric AnalysisCell AdhesionPathologyCancer BiologyTumor Biology +14

Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma

Y. Kato, Masakazu Yashiro, Satoru Noda, +10

British Journal of Cancer

DNA methyltransferase inhibitor 5‐aza‐CdR enhances the radiosensitivity of gastric cancer cells

Hong Qiu, Masakazu Yashiro, Osamu Shinto, +2

Cancer Science

Gastric Cancer CellsPathologyCancer BiologyTumor BiologyGastrointestinal Oncology +14

Synergistic antitumor effects of FGFR2 inhibitor with 5‐fluorouracil on scirrhous gastric carcinoma

Masakazu Yashiro, Osamu Shinto, Kazunori Nakamura, +6

International Journal of Cancer

Chemoprevention StrategySgc CellsPathologyFgfr2 InhibitorTumor Biology +15

Phosphorylated Smad2 in Advanced Stage Gastric Carcinoma

Osamu Shinto, Masakazu Yashiro, Takahiro Toyokawa, +11

BMC Cancer

A Novel Transforming Growth Factor β Receptor Kinase Inhibitor, A-77, Prevents the Peritoneal Dissemination of Scirrhous Gastric Carcinoma

Hidemi Kawajiri, Masakazu Yashiro, Osamu Shinto, +9

Clinical Cancer Research

RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility

Tasuku Matsuoka, Masakazu Yashiro, Y. Kato, +3

Clinical & Experimental Metastasis

Tumor BiologyMedicineMediates PlasticityPathologyCancer Biology +2

<i>In vitro</i> and <i>in vivo</i> evidence that a combination of lapatinib plus S‐1 is a promising treatment for pancreatic cancer

Masahiro Komoto, Bunzo Nakata, Takafumi Nishii, +6

Cancer Science